BIBilcare Limited
Consumer Durable · Packaging & Containers · NSE · as of 2026-10-26 (delayed ~30 min in market hours)
Bilcare Limited provides pharmaceutical packaging research solutions in India and internationally. The company offers aluminum foils, polymer films, and anti-counterfeiting packaging solutions for solid dosage pharmaceutical products and other applications; and blister films and foils, lidding foils, cr foils, and laminates. It also engages in the provision of clinical trial supplies, clinical trial management, and brand protection technologies services; and research and development services comprising formulation stability studies, blister/foil design and development, pharma brand innovation, analytical research and market study, and packaging trials and audit. Bilcare Limited was incorporated in 1987 and is headquartered in Pune, India.
Price & Volume
Loading chart…
Key Ratios
“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.
Active Pattern Signals
None of the 16 pattern scanners currently detects a setup on BI — signals appear here automatically when one forms (checked on every data refresh). The Trade Plan on the right always provides stop-loss and target levels regardless.
Why avoid
- • Risk gate: safety score is only 30/100 — volatility, drawdown or liquidity is too poor for a buy call, whatever the chart says
- • ROE: 0.9%
- • ROCE: 3.0%
- • RSI: 30
- • MACD: bearish
Bull case
- • Revenue growth: 21.2% YoY
- • Profit growth: 321.8% YoY
- • Promoter holding: 66.7%
- • Volume: 2.3x 20-day average
Bear case
- • ROE: 0.9%
- • ROCE: 3.0%
- • RSI: 30
- • MACD: bearish
Key risks
- • Elevated volatility / drawdown profile — size positions accordingly
- • ROE: 0.9%
- • ROCE: 3.0%
Algorithmic analysis for research only — not SEBI-registered investment advice.
Trade Plan
Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹3.23). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.